Loading...

Athenex, Inc.

ATNXNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.20
$0.00(0.00%)

Athenex, Inc. ATNX Peers

See (ATNX) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ATNX$0.20+0.00%2.3M-0.02-$10.45N/A
ZTS$156.17+0.24%69.5B28.09$5.56+1.20%
TAK$15.10+0.27%47.5B65.65$0.23+3.90%
HLN$10.38-0.38%46.7B24.14$0.43+1.13%
TEVA$16.76+1.24%19.2B-14.56-$1.15N/A
ITCI$131.87+0.00%14B-180.64-$0.73N/A
RDY$15.07-1.66%12.5B19.33$0.78+0.64%
NBIX$125.42-1.02%12.4B42.51$2.95N/A
CTLT$63.48+0.00%11.5B-27.84-$2.28N/A
VTRS$9.01-1.21%10.6B-2.83-$3.18+5.35%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ATNX vs ZTS Comparison

ATNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ATNX stands at 2.3M. In comparison, ZTS has a market cap of 69.5B. Regarding current trading prices, ATNX is priced at $0.20, while ZTS trades at $156.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ATNX currently has a P/E ratio of -0.02, whereas ZTS's P/E ratio is 28.09. In terms of profitability, ATNX's ROE is +0.22%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, ATNX is less volatile compared to ZTS. This indicates potentially lower risk in terms of short-term price fluctuations for ATNX.

Stock Price Comparison

Loading...

Frequently Asked Questions

;